A Redcliff, Alberta man claims a WestJet flight attendant made inappropriate comments about his weight during a December 2025 flight. The incident is raising questions about airline passenger treatment.
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Generic versions of weight-loss drug Ozempic could slash costs from $400 to under $100 per month in Quebec following a key patent expiration, potentially increasing access for hundreds of thousands.
Professor Svetlana Mojsov, whose research led to revolutionary drugs like Ozempic, has been awarded the 2026 King Faisal Prize in Medicine. Her work is tackling a global obesity crisis.
Novo Nordisk launches Wegovy pill in the U.S., providing a flexible, needle-free option for weight management. Learn about this new alternative to injectable medications.
Dr. Sue Pedersen advises patients to consult their doctors individually about using generic or brand-name Ozempic. A pivotal moment for diabetes and weight-loss treatment access in Canada.
Couples in mixed-weight relationships reveal the intrusive and hurtful comments they receive, challenging societal stigma and affirming that love transcends size. Read their powerful stories.
A new report reveals age discrimination is impacting Canadian employees over 45. Learn the key findings and what it means for the workforce. Read the full story.
A new U.S. policy ending insurance coverage for gender-affirming care faces a legal challenge from federal employees, who call it discriminatory. The complaint was filed Thursday.
Explore how GLP-1 drugs like Ozempic are transforming workplace dynamics, from employer-sponsored benefits to shifting social etiquette. Discover the data behind this growing trend.
A woman seeks advice after a friend makes hurtful remarks about her weight loss and grief. Jeanne Phillips offers two clear strategies for dealing with tactless comments. Read the full dilemma and solution.
Explore how social media trends and digital health apps are transforming access to GLP-1 medications in Canada, moving beyond traditional healthcare channels.
The University of Oklahoma dismissed a teaching assistant after an investigation found she was 'arbitrary' in failing a student's paper citing the Bible on gender. Explore the clash over academic freedom and DEI.
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
A federal jury found the owner of a Rapid City hotel liable for discriminating against Native Americans, ordering tens of thousands in damages. The case highlights ongoing racial tensions.
A federal jury finds a South Dakota hotel owner liable for discrimination against Native Americans. The case stems from a 2022 lawsuit following service denials. Read the full story.
The head of the U.S. Equal Employment Opportunity Commission is urging white men to come forward with discrimination claims, aligning with Trump's anti-DEI agenda. Critics call it a misunderstanding of DEI's goals.
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Weight Watchers launches a fully integrated digital platform offering comprehensive support for members using GLP-1 medications, featuring personalized nutrition, coaching, and community. Discover the future of weight management.
A Toronto model reports being forced from an Uber late at night after the driver refused to transport a Jewish person. Uber has apologized, calling discrimination 'unacceptable.'
A University of Oklahoma student's failing essay grade, citing biblical views on gender, led to a religious discrimination complaint and the instructor's administrative leave. Explore the latest campus culture war clash.
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
Discover Tanice, the Toronto Sun's latest SUNshine Girl - a model and entrepreneur balancing garden maintenance with fitness passions. Learn her inspiring story today!
Erik Burggraaf of St. Catharines awarded $28,000+ after Human Rights Tribunal finds call-centre company engaged in discriminatory practices against blind employee.
Baltimore County officials confirm AI system didn't discriminate based on color when mistaking student's chip bag for gun. Investigation reveals technical error rather than racial bias.
Novo Nordisk's experimental obesity drug amycretin demonstrates significant weight loss results in mid-stage study, advancing to late-phase testing for diabetes patients.
Justine Lindsay, NFL's first transgender cheerleader, says Carolina Panthers fired her for being trans. Read her powerful response and the organization's silence.
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.